ArticleIndian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
Exploring the Frontiers of Diabetes Vaccination.
Article in Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is undeniably one of the most prevalent global health problems with a high risk burden. The present forms of management, insulin administration and lifestyle changes, may address the origins and consequences of the disease to some extent, but the answers are still far from being complete. This phenomenon is bringing in a rising number of people who seek for new therapies and immunization. Through the years, vaccine usage for prevention of infectious diseases has been researched for its potential use in the delay, prevention, or reversal of diabetes. These vaccines, which aim at different processes, including autoimmunity, inflammation, and insulin resistance, play a role in both Type 1 and Type 2 diabetes. Among the candidates for vaccine types are the IA-2 peptide vaccines, glucose-regulating vaccines, incretin-based vaccines, and protein-based vaccines. In this review, we offer a snapshot of the current efforts in diabetes vaccine development, describing the target molecules on the antigens, their mechanisms of action, and the research progress status. It highlights the imperativeness of importance of ongoing investigations for the invention of vaccines as well as the provision of new therapeutic options for diabetic persons.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.